VISCERAL LEISHMANIASIS MIMICKING A FLARE OF SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:19
作者
BRAUN, J
SIEPER, J
SCHULTE, KL
THIEL, E
JANITSCHKE, K
机构
[1] Rheumatologische Arbeitsgruppe, Medizinische Klinik und Poliklinik, Freie Universität Berlin, Berlin, 1000 Berlin 45
[2] Abteilung für Allgemeine Innere Medizin, Freie Universität Berlin, Berlin
[3] Hamatologische und Onkologische Abteilung, Klinikum Steglitz, Freie Universität Berlin, Berlin
[4] Abteilung für Klinische Parasitologie, Robert-Koch-Institut, Berlin
关键词
SLE; VISCERAL LEISHMANIASIS; SPLENOMEGALY; PANCYTOPENIA;
D O I
10.1007/BF02206670
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Fever in systemic lupus erythematosus (SLE) may be caused by exacerbation of the disease itself or by infection. We report on a patient with a long standing history of SLE that was complicated by fever and pancytopenia with no splenomegaly. SLE disease activity was suspected because of an elevated DNA-antibody titer. The early positive response to corticoid therapy may have masked the underlying infection. Visceral leishmaniasis was diagnosed by a repeated bone marrow biopsy and serological testing.
引用
收藏
页码:445 / 448
页数:4
相关论文
共 8 条
[1]
Martinez L., de Letona J., Masa Vazquez C., Perez Maestu R., 2nd letter: Visceral leishmaniasis as an opportunistic infection, Lancet, 1, (1986)
[2]
Badaro R., Jones T.C., Carvalho E.M., Sampaio D., Reed S.G., Barral A., Teixera R., Johnson W.D., New perspectives on a subclinical form of visceral leishmaniasis, J Infect Dis, 154, pp. 1003-1011, (1986)
[3]
Fernandez-Guerrero M., Aguado J., Buzon L., Barros C., Motalban C., Martin T., Bouza E., Visceral lesishmaniasis in immunocompromised hosts, The American Journal of Medicine, 83, pp. 1098-1102, (1987)
[4]
Chulay J.D., Bhatt S.M., Muigai R., Et al., A comparison of three dosage regimens of sodium stibogluconate in the treatment of viscerall leishmaniasis in Kenya, J Infect Dis, 148, pp. 148-155, (1983)
[5]
Carvalho E.M., Bacellar O., Barral A., Badaro R., Johnson W.D., Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated, J Clin Invest, 83, pp. 860-864, (1989)
[6]
Wallis P.J.W., Clark C.J.M., Visceral leishmaniasis complicating systemic lupus erythematosus, case report, Ann Rheum Dis, 42, pp. 201-202, (1983)
[7]
Cohen J., Pinching A.J., Rees A.J., Peters D.K., Infection and Immunosuppression, Q J Med, 201, pp. 1-15, (1982)
[8]
Neva F.A., Immunotherapy for parasitic disease (editorial), N Engl J Med, 322, pp. 55-57, (1990)